ChemComm
Communication
the methodology in other heterocycle synthesis and bioactive
evaluation of imidazo[1,5-c]quinazolines is currently underway
in our laboratory.
Financial support from National Natural Science Foundation
of China (21272114 and 90913023) and the National Natural
Science Fund for Creative Research Groups (21121091) is grate-
fully acknowledged.
Scheme 3 Large scale synthesis of 3ma.
Further control experiments have been performed to obtain
insights into the mechanism (Scheme S1, see ESI†). It was thought
that iodo product 5 may be the key reaction intermediate derived
from 1a. However, 1a under standard conditions in the absence of
2a and acetic acid did not afford 5 (Scheme S1A, ESI†), suggesting
that an ‘in situ iodination’ based oxidative coupling pathway2c could
be excluded. When 20 mol% PhI(OAc)2 was employed, the reaction
did not work (Scheme S1B, ESI†). This result indicated hypervalent
iodine reagents might not be involved in the transformation. Adding
a radical inhibitor BHT (2,6-di-tert-butyl-4-methylphenol) or TEMPO
(2,2,6,6-tetramethylpiperidine-N-oxyl) to the reaction system, a nega-
tive influence on the yield was observed (Scheme S1C, ESI†). This
result suggested that the reaction probably proceeded via a free
radical process. When 1a was used as a substrate under standard
conditions in the absence of benzylamines, an unexpected benzylic
acetate 6 was obtained (Scheme S1D, ESI†). To help ascertain
whether 6 is a potential intermediate, we explored the coupling of
6 with 2a under standard conditions (Scheme S1E, ESI†). The
desired product was obtained in 76% yield within 5 h, suggesting
that 6 was most likely a possible intermediate for the present
transformation. Additionally, no reaction occurred in the absence
of n-Bu4NI or TBHP, indicating that the proper oxidation state of the
iodine catalyst was an important requirement for reactivity. When
sodium acetate was subjected to the reaction conditions, no benzylic
acetate was detected (Scheme S1F, ESI†). Thus, a benzyl cation is not
involved in this reaction.
On the basis of the above evidence and previously reported
results,9,13 a possible mechanism is proposed as shown in
Scheme S2 (see ESI†). Initially, TBHP decomposes to generate the
tert-butoxyl and tert-butylperoxy radicals in the presence of iodide ions
(Iꢀ). These radicals subsequently abstract hydrogen atoms from the
acetic acid and 1 to provide both the acyloxy and benzylic radical A,
respectively. Then the coupling of these two radicals forms the inter-
mediate 6. B is generated via amination of 6 under current conditions,14
followed by oxidation to give C or C0. Subsequently, C or C0 is oxidized
to E via sp3 C–H functionalization under iodine-catalyzed reaction
conditions. Then E is converted to the product after intramolecular
amination/cyclization and rearrangement in a tandem process.
In summary, a facile and efficient approach to the synthesis
of imidazo[1,5-c]quinazolines was developed via a tandem
reaction following sp3 C–H functionalization under metal-free
conditions. Moreover, the reaction showed a broad scope of
substrates including the common commercially available benzyl-
amines and a-amino acids. The new protocol serves not only as a
method to construct a new class of imidazo-N-heterocycles but also
as a rare example of benzylic primary C–H oxidative amination with
primary amines. The investigation of the mechanism indicated
that benzylic acetate as a possible intermediate was involved in
the reaction. Ongoing research involves further application of
Notes and references
1 For recent reviews, see: (a) H. M. L. Davies and J. R. Manning,
Nature, 2008, 451, 417; (b) F. Collet, C. Lescot and P. Dauban, Chem.
Soc. Rev., 2011, 40, 1926; (c) F. Collet, R. H. Dodd and P. Dauban,
Chem. Commun., 2009, 5061; (d) R. Samanta and A. P. Antonchick,
Synlett, 2012, 809; (e) D. N. Zalatan and J. Du Bois, Top. Curr. Chem.,
2010, 292, 347.
2 For recent reviews, see: (a) V. V. Zhdankin and P. J. Stang, Chem. Rev.,
2008, 108, 5299; (b) T. Dohi and Y. Kita, Chem. Commun., 2009, 2073;
(c) P. Finkbeiner and B. J. Nachtsheim, Synthesis, 2013, 45, 979.
3 For recent examples, see: (a) Y. Yan, Y. Zhang, C. Feng, Z. Zha and
Z. Wang, Angew. Chem., Int. Ed., 2012, 51, 8077; (b) L. Ma, X. Wang,
W. Yu and B. Han, Chem. Commun., 2011, 47, 11333; (c) J. Xie,
H. Jiang, Y. Cheng and C. Zhu, Chem. Commun., 2012, 48, 979;
(d) Y. P. Zhu, M. Lian, F. C. Jia, M. C. Liu, J. J. Yuan, Q. H. Gao and
A. X. Wu, Chem. Commun., 2012, 48, 9086; (e) W.-P. Mai, H.-H. Wang,
Z.-C. Li, J.-W. Yuan, Y.-M. Xiao, L.-R. Yang, P. Mao and L.-B. Qu,
Chem. Commun., 2012, 48, 10117; ( f ) M. Lamani and K. R. Prabhu,
Chem.–Eur. J., 2012, 18, 14638; (g) X. Zhang and L. Wang, Green
Chem., 2012, 14, 2141; (h) J. A. Souto, D. Zian and K. Muniz, J. Am.
Chem. Soc., 2012, 134, 7242; (i) W. Wei, Y. Shao, H. Y. Hu, F. Zhang,
C. Zhang, Y. Xu and X. B. Wan, J. Org. Chem., 2012, 77, 7157.
4 (a) H. J. Kim, J. Kim, S. H. Cho and S. Chang, J. Am. Chem. Soc., 2011,
133, 16382; (b) Q. Xue, J. Xie, H. Li, Y. Cheng and C. Zhu, Chem.
Commun., 2013, 49, 3700.
5 L. F. Tietze, Chem. Rev., 1996, 96, 115.
6 (a) M. N. Silverstein, R. M. Petitt, L. A. Solberg, J. S. Fleming,
R. C. Knight and L. P. Schacter, N. Engl. J. Med., 1988, 318, 1292;
(b) H. Gisslinger, M. Gotic, J. Holowiecki, M. Penka, J. Thiele,
H. M. Kvasnicka, R. Kralovics, P. E. Petrides and A. S. Grp, Blood,
2013, 121, 1720; (c) M. C. Venuti, R. A. Stephenson, R. Alvarez,
J. J. Bruno and A. M. Strosberg, J. Med. Chem., 1988, 31, 2136.
7 (a) H. C. Jackson, H. C. Hansen, M. Kristiansen, P. D. Suzdak,
H. Klitgaard, M. E. Judge and M. D. B. Swedberg, Eur. J. Pharmacol.,
1996, 308, 21; (b) Y. D. Zhang, Z. Chen, Y. J. Lou and Y. P. Yu, Eur. J. Med.
Chem., 2009, 44, 448; (c) J. W. Chern, P. L. Tao, M. H. Yen, G. Y. Lu,
C. Y. Shiau, Y. J. Lai, S. L. Chien and C. H. Chan, J. Med. Chem., 1993,
36, 2196; (d) M. A. H. Ismail, M. N. Y. Aboul-Enein, K. A. M. Abouzid and
R. A. T. Serya, Bioorg. Med. Chem., 2006, 14, 898.
8 (a) A. A. Kalinin, A. D. Voloshina, N. V. Kulik, V. V. Zobov and V. A.
Mamedov, Eur. J. Med. Chem., 2013, 66, 345; (b) D.-Q. Shi, S.-F. Rong,
G.-L. Dou and M.-M. Wang, J. Heterocycl. Chem., 2009, 46, 971;
(c) A. Mishra and S. Batra, Synthesis, 2009, 3077; (d) G. Li, R. Kakarla,
S. W. Gerritz, A. Pendri and B. Q. Ma, Tetrahedron Lett., 2009, 50, 6048.
9 Y. Yan, Y. Zhang, Z. Zha and Z. Wang, Org. Lett., 2013, 15, 2274.
10 (a) L. Zhang, Z. Gao, C. Peng, Z.-Y. Bin, D. Zhao, J. Wu, Q. Xu and
J.-X. Li, Mol. Diversity, 2012, 16, 579; (b) D. Zhao, M. X. Zhu, Y. Wang,
Q. Shen and J. X. Li, Org. Biomol. Chem., 2013, 11, 6246; (c) D. Zhao,
Q. Shen, Y.-R. Zhou and J.-X. Li, Org. Biomol. Chem., 2013, 11, 5908.
11 For the same regioselectivity of 2,4-dimethylquinazoline in Mannich
reaction, see: J. Siegle and B. E. Christensen, J. Am. Chem. Soc., 1951,
73, 5777.
12 (a) Q. Wang, C. Wan, Y. Gu, J. Zhang, L. Gao and Z. Wang, Green
Chem., 2011, 13, 578; (b) Y. Yan and Z. Wang, Chem. Commun., 2011,
47, 9513; (c) Q. Wang, S. Zhang, F. Guo, B. Zhang, P. Hu and
Z. Wang, J. Org. Chem., 2012, 77, 11161; (d) W. Xu, U. Kloeckner and
B. J. Nachtsheim, J. Org. Chem., 2013, 78, 6065.
13 (a) H. Huang, X. Ji, W. Wu and H. Jiang, Adv. Synth. Catal., 2013,
355, 170; (b) J. Zhang, D. Zhu, C. Yu, C. Wan and Z. Wang, Org. Lett.,
2010, 12, 2841; (c) E. Shi, Y. Shao, S. Chen, H. Hu, Z. Liu, J. Zhang
and X. Wan, Org. Lett., 2012, 14, 3384.
14 For copper-catalyzed amination reaction of benzylic acetate, see:
G. Pelletier and D. A. Powell, Org. Lett., 2006, 8, 6031.
4304 | Chem. Commun., 2014, 50, 4302--4304
This journal is ©The Royal Society of Chemistry 2014